Biomarkers for cardiovascular disease
We are looking for:
Students in health, medical engineering, biomedical sciences/engineering, technology, business
Status
Finished
Spots
8
Registration deadline
12 November 2022
Sprintday
26 September 2022
1. Description of the Challenge
It is expected that 1 out of 5 people have elevated levels of a biomarker called lipoprotein(a).
These people have significant increased risks on cardiovascular disease. The key problem is that while so many people suffer from this condition, almost nobody knows, because very few people are tested for lipoprotein(a).
2. Expected Outcome
Out-of-the box and creative ideas to increase testing in the Netherlands for lipoprotein(a).
About Novartis Pharma BV
Our purpose is to reimagine medicine to improve and extend people's lives. We use innovative science and technology to address some of society's most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.
View organisation